Amgen Inc. buy dokem
Start price
09.01.17
/
50%
€142.96
Target price
03.02.17
€148.83
Performance (%)
4.33%
End price
03.02.17
€149.15
Summary
This prediction ended on 03.02.17 with a price of €149.15. The BUY prediction by dokem finished with a performance of 4.33%. dokem has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | -3.663% | -3.663% | 10.577% | 26.401% |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % | 45,10 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % | 76,36 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % | 49,59 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % | 57,07 % |
Comments by dokem for this prediction
In the thread Amgen Inc. diskutieren
dokem stimmt dem Sentiment von 'Buy' zu
dokem stimmt am 09.01.2017 dem Buy-Gesamtsentiment mit dem Kursziel 182.04$ zu.
(Zielkurs erreicht)


